StockWatch
·
HomeLiveWeekly
Biotechnology: Biological Products (No Diagnostic Substances)
AGM/EGMMay 27, 2026, 07:16 AM

Agomab Announces Results of Annual General Meeting

AI Summary

Agomab Therapeutics NV announced the results of its Annual General Meeting, which took place on May 26, 2026. The company furnished a press release detailing these results as Exhibit 99.1 to its Form 6-K filing.

Key Highlights

  • Annual General Meeting held on May 26, 2026.
  • Results of the Annual General Meeting were announced on May 27, 2026.
View SEC Filing
AGMB
Biotechnology: Biological Products (No Diagnostic Substances)
Agomab Therapeutics NV

Price Impact

More from AGMB

Clinical Trial7h ago

Agomab Therapeutics Announces Phase 2b NOV-ERA Study Design for Ontunisertib

Clinical Trial7h ago

Agomab Aligns with FDA on Phase 2b Study Design for Ontunisertib

AGM/EGMMay 27, 5:01 AM

Agomab AGM Approves Financials, Reappoints Directors

More in AGM/EGM

PSEC5h ago

Prospect Capital Adjourns Special Stockholder Meeting to July 7

ASTL6h ago

Algoma Steel Shareholders Elect Directors, Approve Auditor

PRKS6h ago

United Parks & Resorts Holds 2026 Annual Meeting